Integral Health Asset Management, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001773206
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2024 · 69 positions · Total reported value $999.53M · Top-10 concentration 47.4% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 75.2% · 35 new · 28 cut · 31 exited
Active Share (vs S&P 500): 97.5% · vs QQQ: 98.1% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -11.2% · vs SPY -13.3% · Prev Value $2.22B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -0.3% · vs SPY -2.5% · Latest Value $1.54B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q2 2024 13F filing, Integral Health Asset Management, LLC disclosed 69 equity positions with a combined reported value of $999.53M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 47.4% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2024 were INSM ($103.85M), THC ($66.52M), CYTK ($54.18M). By sector, the heaviest allocations are Health Care 82.7%, Industrials 2.2%. Versus the prior quarter, allocation shifted toward Health Care (+5.9pp) and away from Consumer Discretionary (-0.8pp), Industrials (-2.1pp).
Versus the prior quarter, Integral Health Asset Management, LLC opened 35 new positions, trimmed 28 and fully exited 31, a turnover rate of 75.2% of positions. The portfolio's overlap with the prior quarter was 47% of names.
The largest new positions opened in Q2 2024 were BDX ($17.53M), EW ($13.86M), TMO ($13.82M).
Of the 31 positions fully exited versus the prior quarter, the largest were WBA ($28.20M), ABBV ($24.58M), CRL ($17.61M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2024)
Fully Exited (vs previous quarter)
- WBA WALGREENS BOOTS ALLIANCE INC · prev qtr: $28.20M
- ABBV ABBVIE INC · prev qtr: $24.58M
- CRL CHARLES RIV LABS INTL INC · prev qtr: $17.61M
- REGN REGENERON PHARMACEUTICALS · prev qtr: $16.36M · history
- PEN PENUMBRA INC · prev qtr: $15.62M
- DXCM DEXCOM INC · prev qtr: $13.87M
- SWAV SHOCKWAVE MEDICAL INC · prev qtr: $13.03M
- AVTR AVANTOR INC · prev qtr: $12.79M
Insider Transactions (Form 4)
Latest Integral Health Asset Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Integral Health Asset Management, LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 90 positions worth $2.22B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-119048 (status: Approved), registered 2020-07-14
- Regulatory AUM (Form ADV): $1.87B as of 2026-03-26
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
- Website: integralhlth.com
Portfolio Structure
- 90 positions · $2.22B reported value (Q2 2026)
- Top 10 holdings = 41.0% of reported value
- Largest position: INSM (INSMED INC) at 7.7%
- Average position size: $24.69M
Sector Tilt
- Health Care 92.9%
- Consumer Staples 5.1%
- Industrials 1.1%
- (classified holdings cover 99% of value)
Quarterly Activity
- Q2 2026: 28 new, 25 added, 22 reduced, 24 exited
- 15 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.55M | $103.85M | 10.39% | Add | |
| 2 |
|
500.00K | $66.52M | 6.66% | Add | |
| 3 |
|
1.00M | $54.18M | 5.42% | Add | |
| 4 |
|
650.00K | $50.06M | 5.01% | Add | |
| 5 |
|
80.00K | $43.35M | 4.34% | Add | |
| 6 |
|
340.00K | $36.65M | 3.67% | Add | |
| 7 |
|
300.00K | $31.94M | 3.19% | Add | |
| 8 |
|
1.10M | $29.73M | 2.98% | Add | |
| 9 |
|
235.00K | $29.09M | 2.91% | Hold | |
| 10 |
|
75.00K | $28.02M | 2.80% | Add | |
| 11 |
|
300.00K | $25.74M | 2.58% | Reduce | |
| 12 |
|
130.00K | $24.04M | 2.40% | Add | |
| 13 |
|
400.00K | $19.26M | 1.93% | Add | |
| 14 |
|
500.00K | $18.09M | 1.81% | Add | |
| 15 |
|
400.00K | $17.92M | 1.79% | Add | |
| 16 |
|
75.00K | $17.53M | 1.75% | New | |
| 17 |
|
50.00K | $16.53M | 1.65% | Add | |
| 18 |
|
85.00K | $15.61M | 1.56% | Add | |
| 19 |
|
275.00K | $15.18M | 1.52% | Add | |
| 20 |
|
45.00K | $14.11M | 1.41% | Hold | |
| 21 |
|
150.00K | $13.86M | 1.39% | New | |
| 22 |
|
25.00K | $13.82M | 1.38% | New | |
| 23 |
|
100.00K | $13.69M | 1.37% | New | |
| 24 |
|
250.00K | $13.25M | 1.33% | Reduce | |
| 25 |
|
325.00K | $12.61M | 1.26% | Reduce | |
| 26 |
|
40.00K | $12.50M | 1.25% | New | |
| 27 |
|
250.00K | $11.91M | 1.19% | New | |
| 28 |
|
20.00K | $11.68M | 1.17% | New | |
| 29 |
|
950.00K | $11.12M | 1.11% | Add | |
| 30 |
|
400.00K | $10.87M | 1.09% | Reduce | |
| 31 |
|
145.00K | $9.93M | 0.99% | Add | |
| 32 |
|
200.00K | $9.70M | 0.97% | New | |
| 33 |
|
220.00K | $9.67M | 0.97% | Add | |
| 34 |
|
70.00K | $9.64M | 0.96% | Reduce | |
| 35 |
|
45.00K | $9.46M | 0.95% | New | |
| 36 |
|
10.00K | $9.05M | 0.91% | Reduce | |
| 37 |
|
125.00K | $8.56M | 0.86% | New | |
| 38 |
|
130.00K | $8.30M | 0.83% | Reduce | |
| 39 |
|
150.00K | $8.10M | 0.81% | Reduce | |
| 40 |
|
500.00K | $7.91M | 0.79% | Hold | |
| 41 |
|
60.00K | $7.56M | 0.76% | Add | |
| 42 |
|
325.00K | $7.55M | 0.76% | New | |
| 43 |
|
2.33M | $7.21M | 0.72% | Add | |
| 44 |
|
1.20M | $6.55M | 0.66% | Add | |
| 45 |
|
450.00K | $6.49M | 0.65% | Reduce | |
| 46 |
|
1.77M | $6.39M | 0.64% | Add | |
| 47 |
|
100.00K | $5.92M | 0.59% | Reduce | |
| 48 |
|
25.00K | $5.04M | 0.51% | New | |
| 49 |
|
150.00K | $4.98M | 0.50% | New | |
| 50 |
|
750.00K | $4.89M | 0.49% | Add | |
FAQ
What did Integral Health Asset Management, LLC buy in 2024-Q2?
In its 2024-Q2 13F filing, Integral Health Asset Management, LLC reported 69 equity positions worth $999.53M in aggregate; its largest disclosed positions were INSM ($103.85M), THC ($66.52M), CYTK ($54.18M).
How large is Integral Health Asset Management, LLC's portfolio?
Integral Health Asset Management, LLC reported $999.53M of long equity holdings across 69 positions as of 2024-Q2. Top-10 holdings account for 47.4% of reported value.
What is Integral Health Asset Management, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.